Pharmeasy / API Holdings

On (i) Its acquisition of Thyrocare Technologies, for an aggregate value of USD 844 million (ii) The merger of Ascent Health and 91 Streets to create API Holdings (iii) Several fund-raises from Naspers, TPG, Temasek, JM Financial, B Capital, Everstone, Think Capital, Bessemer Venture Partners, Astarc Ventures, Orios Venture Partners, Trifecta, Innoven, Fundamentum, Eight Roads, CDPQ, LGT, etc. (increasing the total valuation of the company to upwards of USD 6 billion)